BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 22833458)

  • 1. From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease.
    Leuner K; Müller WE; Reichert AS
    Mol Neurobiol; 2012 Aug; 46(1):186-93. PubMed ID: 22833458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.
    Hauptmann S; Scherping I; Dröse S; Brandt U; Schulz KL; Jendrach M; Leuner K; Eckert A; Müller WE
    Neurobiol Aging; 2009 Oct; 30(10):1574-86. PubMed ID: 18295378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.
    Swerdlow RH; Khan SM
    Med Hypotheses; 2004; 63(1):8-20. PubMed ID: 15193340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease.
    Orsucci D; Mancuso M; Ienco EC; Simoncini C; Siciliano G; Bonuccelli U
    Curr Neurovasc Res; 2013 Feb; 10(1):76-80. PubMed ID: 23151073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
    Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
    Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Alzheimer's disease mitochondrial cascade hypothesis.
    Swerdlow RH; Burns JM; Khan SM
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S265-79. PubMed ID: 20442494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation.
    Leuner K; Schütt T; Kurz C; Eckert SH; Schiller C; Occhipinti A; Mai S; Jendrach M; Eckert GP; Kruse SE; Palmiter RD; Brandt U; Dröse S; Wittig I; Willem M; Haass C; Reichert AS; Müller WE
    Antioxid Redox Signal; 2012 Jun; 16(12):1421-33. PubMed ID: 22229260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial translocation of amyloid precursor protein and its cleaved products: relevance to mitochondrial dysfunction in Alzheimer's disease.
    Anandatheerthavarada HK; Devi L
    Rev Neurosci; 2007; 18(5):343-54. PubMed ID: 19544621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Complex I and β-Amyloid Peptide Interplay in Alzheimer's Disease: A Critical Review of New and Old Little Regarded Findings.
    Atlante A; Valenti D
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease.
    Rai SN; Singh C; Singh A; Singh MP; Singh BK
    Mol Neurobiol; 2020 Jul; 57(7):3075-3088. PubMed ID: 32462551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio.
    Schmitt K; Grimm A; Kazmierczak A; Strosznajder JB; Götz J; Eckert A
    Antioxid Redox Signal; 2012 Jun; 16(12):1456-66. PubMed ID: 22117646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mitochondrial secret(ase) of Alzheimer's disease.
    Young KJ; Bennett JP
    J Alzheimers Dis; 2010; 20 Suppl 2():S381-400. PubMed ID: 20442493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
    Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
    Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease.
    Eckert A; Keil U; Marques CA; Bonert A; Frey C; Schüssel K; Müller WE
    Biochem Pharmacol; 2003 Oct; 66(8):1627-34. PubMed ID: 14555243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats.
    Tyumentsev MA; Stefanova NA; Muraleva NA; Rumyantseva YV; Kiseleva E; Vavilin VA; Kolosova NG
    J Alzheimers Dis; 2018; 63(3):1075-1088. PubMed ID: 29710722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
    Bhatia V; Sharma S
    J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
    Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
    J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer's disease.
    Oka S; Leon J; Sakumi K; Ide T; Kang D; LaFerla FM; Nakabeppu Y
    Sci Rep; 2016 Nov; 6():37889. PubMed ID: 27897204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria Localized microRNAs: An Unexplored miRNA Niche in Alzheimer's Disease and Aging.
    Rivera J; Gangwani L; Kumar S
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.